Amgen Inc $125.55

down -1.84


1/8/2014 04:00 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has outperformed the S&P 500 by 3%

Partner Headlines

  1. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  2. Amgen Price Target Raised by Various Analysts

    Benzinga
  3. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  4. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  5. Amgen To Slash Workforce

    IBD
  6. Indexes End Lower As Russia Sanctions Hit Stocks

    IBD
  7. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  8. Earnings Scheduled For July 29, 2014

    Benzinga
  9. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  10. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  11. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  12. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  13. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  14. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  15. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  16. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  17. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  18. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  19. Bind Therapeutics

    IBD
  20. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  21. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  22. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  23. Morning Market Losers

    Benzinga
  24. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  25. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  26. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  27. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  28. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  29. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study

    Benzinga
  30. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  31. Amgen

    IBD
  32. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  33. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  34. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  35. Stocks End Six-Day Win Streak As Techs Sell Off

    IBD
  36. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  37. #PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure ...

    Benzinga
  38. AMGEN

    IBD
  39. Gilead Soars As Hep C Drug Shatters Views; Amgen Misses

    IBD
  40. Rallying Ahead of Earnings

    FoxBusiness
  41. Nasdaq, S&P 500 On Track For Sixth Straight Gain

    IBD
  42. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  43. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  44. Earnings Scheduled For April 22, 2014

    Benzinga
  45. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  46. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  47. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  48. UPDATE: Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response ...

    Benzinga
  49. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  50. Cholesterol drug meets goal

    IBD
Trading Center